Key result
Peripartum cardiomyopathy is a life-threatening condition requiring prompt diagnosis through clinical and instrumental methods, and multidisciplinary management tailored to the pregnancy or postpartum state.
This review summarizes contemporary views on the clinical presentation, diagnostics, and management of peripartum cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to peripartum cardiomyopathy urgency; leaves open standardization of protocols pending higher-level evidence.
The second part of the review of peripartum cardiomyopathy includes contemporary views of a specifics of disease onset. Detailed specifics of the disease onset is provided according to their specificity and diagnostical value. The approaches to diagnostics described beginning from physical examination to instrumental methods. Taking into account of the microparticles role on the disease onset, the importance ov their measurement is highlighted in peripartum cardiomyopathy, especially peripheral vasodilators, diuretics, ACE inhibitors, antiarrhythmic drugs, anticoagulants, pentoxyphilline, bromocryptine, cabergoline. The methods selected of artificial circulation in severe disease course and the data provided on plasmapheresis usage and implantable cardioverter-defibrillator. In general the points of delivery problems discussed.
No takes yet. Share an insight, caveat, or question.
Vatutin et al. (2015) conducted a review in Peripartum cardiomyopathy. Diagnostic and therapeutic strategies was evaluated. Peripartum cardiomyopathy is a life-threatening condition requiring prompt diagnosis through clinical and instrumental methods, and multidisciplinary management tailored to the pregnancy or postpartum state.
Synapse has enriched 10 related papers. Consider them for comparative context: